Kontafarma China Holdings Ltd (HK:1312) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kontafarma China Holdings Ltd has announced changes to its board of directors effective 7 June 2024, revealing a new composition of executive and non-executive members, including Wang Feifei as Chairman and President. The company has also detailed the structure of its seven board committees, specifying the roles of each director across these committees, with clear designations for chairpersons and members.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.